Terumo Corporation is a major Japanese medical technology company known for developing and manufacturing medical devices, healthcare products, cardiovascular technologies, blood-management systems, and other medical solutions. Founded in Japan in 1921, Terumo has grown into a global healthcare company whose products are sold in more than 160 countries and regions.

The company works across several important areas of modern healthcare, including cardiovascular intervention, cardiac surgery, neurovascular treatment, hospital care, diabetes-related products, pharmaceutical solutions, blood collection and processing, and cell technologies.

Terumo Corporation is headquartered in Tokyo, Japan. Its corporate profile lists its establishment date as September 17, 1921, and identifies its main business as the manufacture and sale of medical products and equipment, including blood bags, disposable medical devices, cardiovascular systems, vascular grafts, dialysis-related products, blood glucose monitoring systems, medical electronics and other healthcare products.

Terumo at a Glance

Category Details Company Terumo Corporation Country Japan Founded 1921 Headquarters Tokyo, Japan Main Industry Medical Technology and Healthcare Major Areas Cardiovascular, Blood & Cell Technologies, Hospital Care, Medical Devices Products Sold 160+ countries and regions Employees 31,185 consolidated FY2026 Revenue ¥1,131.9 billion Stock Exchange Tokyo Stock Exchange, Prime Market Stock Code 4543

Terumo’s global business has expanded well beyond its Japanese roots. Its North American operations are particularly important, with the region accounting for around 35% of Terumo Group sales according to the company’s global network information.

What Does Terumo Manufacture?

Terumo manufactures a very broad range of healthcare products. Its portfolio includes products used directly in hospitals, operating rooms, catheterization laboratories, blood centers, laboratories and other healthcare environments.

Some of its major product categories include:

• Cardiovascular intervention devices
• Coronary and peripheral vascular devices
• Catheters and guidewires
• Vascular access products
• Neurovascular devices
• Cardiac surgery systems
• Cardiopulmonary bypass systems
• Oxygenators
• ECMO-related systems
• Artificial vascular grafts
• Stent grafts
• Syringes and needles
• Infusion pumps
• Infusion sets
• IV solutions
• Blood bags
• Blood collection systems
• Automated blood-processing equipment
• Apheresis systems
• Pathogen-reduction systems
• Blood glucose monitoring systems
• Insulin-related products
• Blood pressure monitors
• Digital thermometers
• Pharmaceutical packaging and prefillable syringes

Terumo’s FY2025 financial materials divide its businesses into the Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

1. Terumo Cardiovascular Products

Cardiovascular technology is one of Terumo’s most important areas.

The company develops products used in minimally invasive cardiovascular procedures as well as cardiac surgery. These technologies can assist physicians in treating coronary artery disease, peripheral vascular disease, structural vascular problems and other cardiovascular conditions.

Interventional Cardiology

Terumo’s interventional portfolio includes devices such as:

• Angiographic catheters
• Guidewires
• Introducer sheaths
• Vascular closure devices
• PTCA balloon catheters
• Coronary stents
• Peripheral vascular stents
• Intravascular ultrasound systems
• Imaging catheters

These products can be used during catheter-based procedures where physicians access blood vessels and navigate medical devices toward the treatment area.

2. Vascular Access Devices

Vascular access is an important part of many minimally invasive procedures.

Terumo produces products designed to help physicians establish access to blood vessels and safely introduce catheters and other devices.

Its portfolio includes:

• Introducer sheaths
• Access needles
• Guidewires
• Catheters
• Hemostasis products
• Vascular closure devices

In 2026, Terumo launched the TR Band Distal in Japan for distal radial artery procedures. The device is designed to support hemostasis following distal radial access procedures.

3. Neurovascular Devices

Terumo also operates in the neurovascular field.

Neurovascular products are used in procedures involving blood vessels in the brain, including treatments for cerebral aneurysms and ischemic stroke.

Its product categories include:

• Embolization coils
• Neurovascular stents
• Intrasaccular devices
• Embolization systems
• Aspiration catheters
• Clot-retrieval devices

These technologies support minimally invasive approaches to complex neurological vascular conditions.

4. Terumo Cardiovascular: Heart-Lung Machines and Cardiac Surgery

Terumo’s cardiovascular business is not limited to catheters and stents.

The company also develops technologies used during open-heart surgery.

Cardiopulmonary Bypass Systems

During some cardiac operations, a heart-lung machine temporarily performs functions normally handled by the patient’s heart and lungs.

Terumo develops cardiopulmonary bypass systems that circulate blood during these procedures.

Oxygenators

An oxygenator performs gas exchange outside the body, helping remove carbon dioxide and add oxygen to blood during cardiopulmonary bypass.

ECMO and Extracorporeal Life Support

Terumo also has extracorporeal life-support technologies designed to support heart and lung function in critically ill patients.

The availability of particular ECMO products varies by country and regulatory approval. Terumo states that some of these systems are commercially available only in Japan and certain Asian countries.

5. Off-Pump Coronary Artery Bypass Surgery

Terumo also develops products used in off-pump coronary artery bypass procedures.

In an off-pump procedure, the heart continues beating while the surgeon works on the coronary arteries. Stabilization equipment can help keep the specific portion of the heart being operated on relatively steady.

Terumo’s cardiovascular portfolio therefore covers both conventional cardiopulmonary-bypass-supported surgery and selected technologies for beating-heart procedures.

6. Vascular Grafts and Aortic Technologies

Another important Terumo business area is vascular surgery.

The company develops:

• Artificial vascular grafts
• Stent grafts
• Aortic repair technologies
• Other vascular surgery products

These technologies can be used in the treatment and repair of damaged or diseased blood vessels.

7. Blood Management and Blood Collection

Blood management is one of Terumo’s major global healthcare activities.

The company manufactures products used by blood centers and healthcare organizations for the collection, processing and management of blood and blood components.

Major categories include:

• Blood bags
• Blood collection systems
• Component collection systems
• Automated blood-processing systems
• Centrifugal apheresis systems
• Pathogen-reduction technologies
• Plasma donation systems
• Cell-processing technologies

Terumo’s Blood and Cell Technologies business operates internationally and focuses on technologies supporting donors, patients and healthcare professionals.

8. Apheresis Technology

Apheresis is a process in which specific components of blood are collected while the remaining components are returned to the donor or patient.

Terumo develops automated systems used for blood-component collection and related applications.

These technologies can be important for:

• Plasma collection
• Platelet collection
• Therapeutic procedures
• Cell collection
• Blood-component processing

9. Blood Bags and Collection Systems

Blood bags are fundamental products used by blood banks and hospitals.

Terumo manufactures blood bags and related collection systems designed to support the safe collection, storage and processing of blood and blood components.

Its blood-management business also includes automated systems that can help healthcare organizations process blood more efficiently.

10. Cell Technologies

Terumo has expanded beyond traditional blood collection into cell-related technologies.

Its Blood and Cell Technologies business includes technologies for cell processing and expansion.

These technologies can support advanced healthcare and research applications involving cells and biological materials.

11. Hospital Care Products

Terumo also supplies products used in everyday hospital care.

Its Medical Care Solutions business includes products such as:

• Syringes
• Infusion pumps
• Syringe pumps
• Infusion lines
• IV solutions
• Pain-management products
• Peritoneal dialysis fluids
• Adhesion barriers

These products are used across hospitals and other healthcare environments.

12. Infusion Pumps and IV Therapy

Infusion therapy is another significant Terumo product area.

The company develops equipment and consumables used to administer fluids and medicines.

Examples include:

• Infusion pumps
• Syringe pumps
• Infusion lines
• IV administration products
• IV solutions

These products are designed for controlled delivery of fluids and medications under clinical supervision.

13. Diabetes and Life-Care Products

Terumo also has a Life Care Solutions business.

This area includes:

• Blood glucose monitoring systems
• Disposable needles for pen injectors
• Insulin patch pumps
• Blood pressure monitors
• Digital thermometers

The products are aimed at supporting monitoring and management of everyday health conditions.

14. Pharmaceutical Solutions

Terumo also works with pharmaceutical companies.

Its Pharmaceutical Solutions business provides technologies and manufacturing capabilities associated with drug-delivery systems and pharmaceutical packaging.

Products and services include:

• Prefillable syringes
• Needles for pharmaceutical packaging
• Drug-kit components
• Contract manufacturing
• Pharmaceutical-device solutions

This allows Terumo to participate not only in medical-device markets but also in the infrastructure used to package and deliver medicines.

15. Terumo’s Three Major Business Companies

Terumo’s current corporate structure highlights three major operating companies:

Cardiac and Vascular Company

This includes:

• Interventional cardiovascular products
• Neurovascular technologies
• Cardiovascular surgery
• Vascular grafts
• Aortic products

For fiscal 2024, this business generated approximately ¥624.4 billion in revenue, representing about 60% of Terumo Group revenue.

Medical Care Solutions Company

This area covers:

• Hospital care
• Infusion
• Life-care products
• Pharmaceutical solutions

It generated approximately ¥211.2 billion in FY2024 revenue.

Blood and Cell Technologies Company

This business focuses on:

• Blood collection
• Blood component processing
• Apheresis
• Blood bags
• Pathogen reduction
• Cell technologies
• Plasma collection

FY2024 revenue was approximately ¥200.3 billion.

16. Terumo’s Global Presence

Terumo has developed a large international manufacturing, research and commercial network.

Its products are sold in more than 160 countries and regions. The company reported 22 R&D sites and 29 production sites in its 2025 integrated report, alongside approximately 30,689 Terumo Group employees for fiscal 2024.

The Americas are particularly significant to Terumo’s business. The company describes North America as its largest market outside Japan and an important center for research, development and production.

17. Terumo in Japan

Terumo’s headquarters are located in Hatagaya, Shibuya-ku, Tokyo.

The company also has multiple Japanese facilities, including the Shonan Center, Terumo Medical Pranex, Fujinomiya Factory, Ashitaka Factory, Kofu Factory and other operations.

Japan remains an important market and manufacturing base for the company.

18. Terumo’s Research and Innovation

Medical technology requires continuous development because hospitals need devices that are safer, smaller, more accurate and easier for healthcare professionals to use.

Terumo invests significantly in research and development across:

• Cardiovascular intervention
• Neurovascular treatment
• Cardiac surgery
• Blood processing
• Cell technologies
• Digital healthcare
• Infusion therapy
• Pharmaceutical solutions
• Minimally invasive procedures

In FY2024, Terumo reported R&D expenses of approximately ¥74.2 billion, equivalent to about 7.2% of revenue. The company also reported approximately 8,500 patents.

19. Why Terumo Is Important in Modern Healthcare

Terumo’s importance comes from the breadth of its medical technology portfolio.

A single healthcare ecosystem can use Terumo products at several different stages—for example, vascular access and catheter-based treatment in a cardiovascular procedure, blood-management products in a blood center, and infusion or hospital-care products during patient treatment.

Its combination of cardiovascular technologies and blood-management systems makes Terumo different from companies that focus on only one medical-device category.

20. Terumo Products in Simple Terms

For readers unfamiliar with medical technology, Terumo’s portfolio can be summarized like this:

Heart and blood vessels:
Catheters, guidewires, balloons, stents, vascular closure devices and imaging technologies.

Brain blood vessels:
Coils, stents, aspiration catheters and clot-retrieval systems.

Heart surgery:
Heart-lung machines, oxygenators, bypass systems and related cardiac-surgery technologies.

Blood management:
Blood bags, blood collection, apheresis and automated blood-processing systems.

Hospital care:
Syringes, infusion pumps, syringe pumps, infusion lines and IV solutions.

Diabetes and monitoring:
Glucose monitoring, insulin-related devices, blood-pressure monitors and thermometers.

Pharmaceutical solutions:
Prefillable syringes, pharmaceutical packaging components and contract manufacturing.

21. Terumo Revenue and Business Scale

Terumo’s business has crossed the ¥1 trillion annual-revenue level.

For fiscal 2024, the company reported revenue of ¥1,036.2 billion. The Cardiac and Vascular Company contributed approximately 60%, Medical Care Solutions approximately 20%, and Blood and Cell Technologies approximately 19%.

Terumo’s latest corporate profile reports revenue of ¥1,131.9 billion for the fiscal year ended March 2026.

22. Frequently Asked Questions About Terumo

What is Terumo?

Terumo Corporation is a Japanese medical technology company that develops and manufactures cardiovascular, blood-management, hospital-care, pharmaceutical and other medical products.

Where is Terumo headquartered?

Terumo’s headquarters are in Tokyo, Japan.

When was Terumo founded?

Terumo was established on September 17, 1921.

What are Terumo’s main products?

Its products include cardiovascular catheters, guidewires, balloons, stents, neurovascular devices, cardiac-surgery systems, oxygenators, blood bags, apheresis systems, infusion pumps, syringes, glucose-monitoring products and pharmaceutical solutions.

Does Terumo manufacture heart-lung machines?

Yes. Terumo Cardiovascular develops cardiopulmonary bypass systems and oxygenators used during cardiac surgery.

Does Terumo make blood bags?

Yes. Blood bags and blood-component collection and processing technologies are an important part of Terumo’s Blood and Cell Technologies business.

Does Terumo make stents?

Yes. Terumo’s cardiovascular portfolio includes coronary stents and peripheral vascular stents.

Does Terumo make neurovascular devices?

Yes. Its neurovascular portfolio includes products such as coils, stents, intrasaccular devices, aspiration catheters and clot-retrieval devices.

Is Terumo available internationally?

Yes. Terumo reports that its products are sold in more than 160 countries and regions.

Conclusion

Terumo Corporation is one of Japan’s major medical technology companies and has built a broad international presence in cardiovascular care, blood management, hospital products and advanced medical technologies.

Its cardiovascular portfolio covers interventional procedures, neurovascular treatment, cardiac surgery and vascular technologies, while its Blood and Cell Technologies business supports blood collection, processing, apheresis and cell-related applications. The company also supplies hospitals with infusion systems, syringes, IV products and other medical-care solutions.

With products sold in more than 160 countries and continued investment in research, manufacturing and medical innovation, Terumo remains an important global supplier of healthcare technology.